Elahere (mirvetuximab soravtansine-gynx) - AbbVie
upifitamab rilsodotin (XMT-1536) - Mersana
budigalimab (ABBV-181) - AbbVie
Jiataile (sacituzumab tirumotecan) - Merck (MSD)
Datroway (datopotamab deruxtecan-dlnk) - Daiichi Sankyo, AstraZeneca
Enhertu (fam-trastuzumab deruxtecan-nxki) - Daiichi Sankyo, AstraZeneca
sofituzumab vedotin (RG 7458) - Roche
PF-06664178 - Pfizer
anetumab ravtansine (BAY 94-9343) - Bayer
RG7882 - Roche
RG7600 - Roche
ZW220 - Zymeworks
lifastuzumab vedotin (DNIB0600A) - Roche
BMS-986148 - BMS
http://www.ncbi.nlm.nih.gov/pubmed/41347223
 
Mei Yang; Qiming Liu; Runji Zhou; Taiqi He; Yonghong Zhao
 
Dec 5, 2025
 
Next